Info
- Utilizzare la checkbox di selezione a fianco di ciascun documento per attivare le funzionalità di stampa, invio email, download nei formati disponibili del (i) record.
Challenges in inflammatory bowel disease [[electronic resource] /] / edited by Derek Jewell ... [et al.]
| Challenges in inflammatory bowel disease [[electronic resource] /] / edited by Derek Jewell ... [et al.] |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Oxford, : Blackwell, 2006 |
| Descrizione fisica | 1 online resource (414 p.) |
| Disciplina | 616.344 |
| Altri autori (Persone) | JewellD. P |
| Soggetto topico |
Inflammatory bowel diseases
Internal medicine |
| ISBN |
1-280-74802-8
9786610748020 0-470-98494-5 0-470-75317-X 1-4051-7176-6 |
| Formato | Materiale a stampa  |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Inflammatory Bowel Disease; Contents; List of Contributors and Editors; Preface; I Clues to aetiology and pathogenesis; 1 Global changes in incidence; 2 The role of genetics in infiammatory bowel disease; 3 Microbial sensing in the intestine by pattern recognition receptors; 4 The role of bacteria; 5 The appendix - how might it infiuence susceptibility to ulcerative colitis: the legend of Qebehsenuef; II Diagnosis and assessment; 6 What are the controversies in histopathological diagnosis?
7 The challenges of using capsule endoscopy in the diagnosis and management of infiammatory bowel disease8 Cross-sectional imaging of infiammatory bowel disease; III Management of ulcerative colitis; 9 Mesalazine for maintenance therapy in ulcerative colitis - how much, how long?; 10 Refractory distal colitis; 11 Pharmabiotics and infiammatory bowel disease - on the verge of evidence-based medicine; 12 Current controversies in the surgical management of ulcerative colitis; 13 What are the causes and treatment of ileoanal pouch dysfunction?; IV Management of Crohn's disease 14 Is mesalazine useful in Crohn's disease?15 Steroids or nutrition?; 16 Do antibiotics have a role in Crohn's disease?; 17 The optimal use of infiiximab in Crohn's disease; 18 Designer drugs: from bench to bedside; 19 Current controversies in the surgical management of Crohn's disease; 20 Perianal Crohn's disease; 21 What is dysplasia?; 22 Colonoscopic surveillance - if and when?; 23 Cancer: new colonoscopic techniques; 24 Molecular markers - a realistic hope?; 25 Adenomas versus dysplasia associated lesion or mass - recognition and management; V Special management problems 26 Growth impairment in children27 Osteopenia; 28 Pregnancy; 29 Can prognosis of ulcerative colitis be predicted?; Index |
| Record Nr. | UNINA-9910830822703321 |
| Oxford, : Blackwell, 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical Dilemmas in Inflammatory Bowel Disease : New Challenges
| Clinical Dilemmas in Inflammatory Bowel Disease : New Challenges |
| Autore | Irving Peter |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Hoboken, : Wiley, 2011 |
| Descrizione fisica | 1 online resource (286 p.) |
| Disciplina | 616.344 |
| Altri autori (Persone) |
SiegelCorey A
RamptonDavid ShanahanFergus |
| Soggetto topico |
Clinical dilemmas
Inflammatory bowel diseases Inflammatory Bowel Diseases Inflammatory bowel diseases - Decision making Inflammatory bowel diseases -- Decision making Intestinal Diseases Gastroenteritis Gastrointestinal Diseases Digestive System Diseases Diseases Medicine Health & Biological Sciences Gastroenterology |
| ISBN |
1-283-24049-1
9786613240491 1-4443-4257-6 1-4443-4254-1 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Clinical Dilemmas inInflammatoryBowel Disease; Contents; Contributors; Preface; Part I: Genes and Phenotype in IBD; 1 Which will take us further in IBD-study of coding variation or epigenetics?; 2 IBD in different ethnic groups: same or different?; Part II: Bugs and IBD-Good, Bad, or Indifferent?; 3 How does the risk of infection influence management of IBD around the world?; 4 Traveling with IBD; 5 What to do about hepatitis B and hepatitis C in patients with IBD; 6 CMV in IBD-passenger or pathogen?; 7 Clostridium difficile in IBD: impact, prevention, and treatment
8 Prebiotics and synbiotics: panacea or placebo9 Worms: light at the end of their burrow; 10 Do we really need to vaccinate all patients with IBD?; Part III: Investigating IBD; 11 Biomarkers in IBD: myth or marvel?; 12 Radiation exposure in IBD: how do we minimize the dangers?; 13 Surveillance colonoscopy in UC: what is the best way to do it?; Part IV: Medical Therapy; 5-ASA; 14 New 5-ASAs for ulcerative colitis: a tiny step or giant stride forward?; 15 Do 5-ASAs prevent cancer?; 16 Why do we still use 5-ASAs in Crohn's disease?; Steroids 17 Steroids in Crohn's disease: do the benefits outweigh the dangers?Immunomodulators; 18 Thioguanine nucleotide measurement: nonadherent, underdosed, shunter, or refractory?; 19 Thiopurines and the sun: what should be done?; 20 Do thiopurines worsen risk and prognosis of cervical neoplasia?; 21 Optimizing use of methotrexate; 22 Which calcineurin inhibitor and when?; Biologics; 23 Are all anti-TNF agents the same?; 24 One drug or two: do patients on biologics need concurrent immunomodulation?; 25 How do we identify patients needing early aggressive therapy and what should we use? 26 What is the role of biologics in UC?27 What can we do with Crohn's patients who fail or lose response to anti-TNF therapy?; 28 Which extraintestinal manifestations of IBD respond to biologics?; 29 Use and abuse of biologics in pregnancy; 30 Is anti-TNF therapy safe to use in people with a history of malignancy?; 31 The risks of immunomodulators and biologics: what should we tell patients?; 32 When, how, and in whom should we stop biologics?; Part V: Other Treatments; 33 Avoiding drug interactions 34 Is there still a role for ursodeoxycholic acid treatment patients with inflammatory bowel disease associated with primary sclerosing cholangitis?35 Stem cell transplantation for Crohn's: will it fulfill its promise?; 36 Complementary therapy: is there a needle in the haystack?; Part VI: Surgical Dilemmas in IBD; 37 Optimizing IBD patients for surgery and recovery; 38 Is surgery the best initial treatment for limited ileocecal Crohn's disease?; 39 Laparoscopic or open surgery for IBD?; 40 Optimizing management of perianal Crohn's disease 41 Does anti-TNF therapy increase the risk of complications of surgery? |
| Record Nr. | UNINA-9910139555703321 |
Irving Peter
|
||
| Hoboken, : Wiley, 2011 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical dilemmas in inflammatory bowel disease [[electronic resource] /] / edited by Peter Irving, David Rampton, Fergus Shanahan
| Clinical dilemmas in inflammatory bowel disease [[electronic resource] /] / edited by Peter Irving, David Rampton, Fergus Shanahan |
| Pubbl/distr/stampa | Malden, MA, : Blackwell Pub. Ltd, 2006 |
| Descrizione fisica | 1 online resource (264 p.) |
| Disciplina | 616.344 |
| Altri autori (Persone) |
IrvingPeter <1970->
RamptonDavid ShanahanFergus |
| Soggetto topico |
Inflammatory bowel diseases
Inflammatory bowel diseases - Decision making |
| ISBN |
1-281-32207-5
9786611322076 0-470-75082-0 0-470-75028-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Clinical Dilemmas in: Inflammatory Bowel Disease; Contents; List of Contributors; Preface; Part 1 Investigating IBD in the 21st Century; 1 Capsule endoscopy: do we need it?; 2 Pathology reports - pitfalls for the unwary; 3 Non-invasive diagnosis and assessment; 4 What is the best way to image perianal Crohn's disease?; 5 Surveillance colonoscopy in UC: alternatives and ways to improve outcome; 6 Abnormal liver tests - what should we do about them?; Part 2 Medical Treatment: Making the Most of What We've Got - 5-ASA drugs; 5-ASA drugs; 7 Is monitoring necessary?
8 Do they have a role in Crohn's disease?Steroids; 9 Steroids in Crohn's: are they obsolete?; Antibiotics for Crohn's disease; 10 Antibiotics: which, when, and for how long?; 11 M ycobacterium av ium paratuberculosis in Crohn's disease: player or spectator?; Immunomodulators; 12 TPMT testing: is it essential?; 13 6-Mercaptopurine or azathioprine?; 14 Thiopurines: how long should we use them for?; 15 Making the most of methotrexate; 16 Cyclosporine: balancing risk and benefit; Infliximab; 17 Contraindications - absolute or relative?; 18 How can we prevent tuberculosis? 19 Dealing with infusion reactions20 Use in ulcerative colitis; 21 Infliximab and surgery: health or hazard?; Nutritional therapy for Crohn's disease; 22 Nutritional therapy for Crohn's disease: is it for adults?; Part 3 Medical Treatment: What's Round the Corner?; 23 Trials and tribulations - interpreting clinical trials in IBD; 24 Genetics - clinical and therapeutic applications; 25 Probiotics - separating science from snakeoil; 26 Worms; 27 Smoking and nicotine - poison for Crohn's, potion for colitis?; 28 Heparin; 29 Leukocytapheresis: filtering out the facts 30 Appendectomy for ulcerative colitis - a therapeutic option?31 Biologic treatments in IBD; 32 Stem cell transplantation for IBD; 33 Complementary and alternative therapy - the way forward or a step back?; Part 4 Common Clinical Challenges: Beyond the Text Book; 34 Functional problems; 35 Psychological stress: something to worry about?; 36 Drugs to avoid; 37 NSAIDs and COX-2 selective agents: cause or cure of pain in IBD?; 38 Iron replacement - is it safe and effective?; 39 Hepatitis B and C viruses - how do they affect management of IBD?; 40 Pregnancy: what drugs can we use? 41 How to prevent growth failure in children42 Predicting outcome in severe UC; 43 Refractory proctitis; 44 CMV co-infection - does it matter?; 45 Treatment of oral Crohn's disease; 46 Pathophysiologic approach to treatment of diarrhea in Crohn's disease; 47 Short bowel; 48 Management of internal fistulae; 49 What is indeterminate colitis?; 50 Pouches for indeterminate colitis?; 51 Colitis-associated cancer: what's the risk to your patients?; 52 What to do with dysplasia, DALMs, and adenomas; Part 5 Managing IBD Outside the Gut; 53 Pyoderma gangrenosum 54 Arthritides - helping the joints without harming the gut |
| Record Nr. | UNINA-9910784972003321 |
| Malden, MA, : Blackwell Pub. Ltd, 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical dilemmas in inflammatory bowel disease [[electronic resource] /] / edited by Peter Irving, David Rampton, Fergus Shanahan
| Clinical dilemmas in inflammatory bowel disease [[electronic resource] /] / edited by Peter Irving, David Rampton, Fergus Shanahan |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Malden, MA, : Blackwell Pub. Ltd, 2006 |
| Descrizione fisica | 1 online resource (264 p.) |
| Disciplina | 616.344 |
| Altri autori (Persone) |
IrvingPeter <1970->
RamptonDavid ShanahanFergus |
| Soggetto topico |
Inflammatory bowel diseases
Inflammatory bowel diseases - Decision making |
| ISBN |
1-281-32207-5
9786611322076 0-470-75082-0 0-470-75028-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Clinical Dilemmas in: Inflammatory Bowel Disease; Contents; List of Contributors; Preface; Part 1 Investigating IBD in the 21st Century; 1 Capsule endoscopy: do we need it?; 2 Pathology reports - pitfalls for the unwary; 3 Non-invasive diagnosis and assessment; 4 What is the best way to image perianal Crohn's disease?; 5 Surveillance colonoscopy in UC: alternatives and ways to improve outcome; 6 Abnormal liver tests - what should we do about them?; Part 2 Medical Treatment: Making the Most of What We've Got - 5-ASA drugs; 5-ASA drugs; 7 Is monitoring necessary?
8 Do they have a role in Crohn's disease?Steroids; 9 Steroids in Crohn's: are they obsolete?; Antibiotics for Crohn's disease; 10 Antibiotics: which, when, and for how long?; 11 M ycobacterium av ium paratuberculosis in Crohn's disease: player or spectator?; Immunomodulators; 12 TPMT testing: is it essential?; 13 6-Mercaptopurine or azathioprine?; 14 Thiopurines: how long should we use them for?; 15 Making the most of methotrexate; 16 Cyclosporine: balancing risk and benefit; Infliximab; 17 Contraindications - absolute or relative?; 18 How can we prevent tuberculosis? 19 Dealing with infusion reactions20 Use in ulcerative colitis; 21 Infliximab and surgery: health or hazard?; Nutritional therapy for Crohn's disease; 22 Nutritional therapy for Crohn's disease: is it for adults?; Part 3 Medical Treatment: What's Round the Corner?; 23 Trials and tribulations - interpreting clinical trials in IBD; 24 Genetics - clinical and therapeutic applications; 25 Probiotics - separating science from snakeoil; 26 Worms; 27 Smoking and nicotine - poison for Crohn's, potion for colitis?; 28 Heparin; 29 Leukocytapheresis: filtering out the facts 30 Appendectomy for ulcerative colitis - a therapeutic option?31 Biologic treatments in IBD; 32 Stem cell transplantation for IBD; 33 Complementary and alternative therapy - the way forward or a step back?; Part 4 Common Clinical Challenges: Beyond the Text Book; 34 Functional problems; 35 Psychological stress: something to worry about?; 36 Drugs to avoid; 37 NSAIDs and COX-2 selective agents: cause or cure of pain in IBD?; 38 Iron replacement - is it safe and effective?; 39 Hepatitis B and C viruses - how do they affect management of IBD?; 40 Pregnancy: what drugs can we use? 41 How to prevent growth failure in children42 Predicting outcome in severe UC; 43 Refractory proctitis; 44 CMV co-infection - does it matter?; 45 Treatment of oral Crohn's disease; 46 Pathophysiologic approach to treatment of diarrhea in Crohn's disease; 47 Short bowel; 48 Management of internal fistulae; 49 What is indeterminate colitis?; 50 Pouches for indeterminate colitis?; 51 Colitis-associated cancer: what's the risk to your patients?; 52 What to do with dysplasia, DALMs, and adenomas; Part 5 Managing IBD Outside the Gut; 53 Pyoderma gangrenosum 54 Arthritides - helping the joints without harming the gut |
| Record Nr. | UNINA-9910825090603321 |
| Malden, MA, : Blackwell Pub. Ltd, 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Clinical dilemmas in inflammatory bowel disease [[electronic resource] /] / edited by Peter Irving, David Rampton, Fergus Shanahan
| Clinical dilemmas in inflammatory bowel disease [[electronic resource] /] / edited by Peter Irving, David Rampton, Fergus Shanahan |
| Edizione | [1st ed.] |
| Pubbl/distr/stampa | Malden, MA, : Blackwell Pub. Ltd, 2006 |
| Descrizione fisica | 1 online resource (264 p.) |
| Disciplina | 616.344 |
| Altri autori (Persone) |
IrvingPeter <1970->
RamptonDavid ShanahanFergus |
| Soggetto topico |
Inflammatory bowel diseases
Inflammatory bowel diseases - Decision making |
| ISBN |
1-281-32207-5
9786611322076 0-470-75082-0 0-470-75028-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto |
Clinical Dilemmas in: Inflammatory Bowel Disease; Contents; List of Contributors; Preface; Part 1 Investigating IBD in the 21st Century; 1 Capsule endoscopy: do we need it?; 2 Pathology reports - pitfalls for the unwary; 3 Non-invasive diagnosis and assessment; 4 What is the best way to image perianal Crohn's disease?; 5 Surveillance colonoscopy in UC: alternatives and ways to improve outcome; 6 Abnormal liver tests - what should we do about them?; Part 2 Medical Treatment: Making the Most of What We've Got - 5-ASA drugs; 5-ASA drugs; 7 Is monitoring necessary?
8 Do they have a role in Crohn's disease?Steroids; 9 Steroids in Crohn's: are they obsolete?; Antibiotics for Crohn's disease; 10 Antibiotics: which, when, and for how long?; 11 M ycobacterium av ium paratuberculosis in Crohn's disease: player or spectator?; Immunomodulators; 12 TPMT testing: is it essential?; 13 6-Mercaptopurine or azathioprine?; 14 Thiopurines: how long should we use them for?; 15 Making the most of methotrexate; 16 Cyclosporine: balancing risk and benefit; Infliximab; 17 Contraindications - absolute or relative?; 18 How can we prevent tuberculosis? 19 Dealing with infusion reactions20 Use in ulcerative colitis; 21 Infliximab and surgery: health or hazard?; Nutritional therapy for Crohn's disease; 22 Nutritional therapy for Crohn's disease: is it for adults?; Part 3 Medical Treatment: What's Round the Corner?; 23 Trials and tribulations - interpreting clinical trials in IBD; 24 Genetics - clinical and therapeutic applications; 25 Probiotics - separating science from snakeoil; 26 Worms; 27 Smoking and nicotine - poison for Crohn's, potion for colitis?; 28 Heparin; 29 Leukocytapheresis: filtering out the facts 30 Appendectomy for ulcerative colitis - a therapeutic option?31 Biologic treatments in IBD; 32 Stem cell transplantation for IBD; 33 Complementary and alternative therapy - the way forward or a step back?; Part 4 Common Clinical Challenges: Beyond the Text Book; 34 Functional problems; 35 Psychological stress: something to worry about?; 36 Drugs to avoid; 37 NSAIDs and COX-2 selective agents: cause or cure of pain in IBD?; 38 Iron replacement - is it safe and effective?; 39 Hepatitis B and C viruses - how do they affect management of IBD?; 40 Pregnancy: what drugs can we use? 41 How to prevent growth failure in children42 Predicting outcome in severe UC; 43 Refractory proctitis; 44 CMV co-infection - does it matter?; 45 Treatment of oral Crohn's disease; 46 Pathophysiologic approach to treatment of diarrhea in Crohn's disease; 47 Short bowel; 48 Management of internal fistulae; 49 What is indeterminate colitis?; 50 Pouches for indeterminate colitis?; 51 Colitis-associated cancer: what's the risk to your patients?; 52 What to do with dysplasia, DALMs, and adenomas; Part 5 Managing IBD Outside the Gut; 53 Pyoderma gangrenosum 54 Arthritides - helping the joints without harming the gut |
| Record Nr. | UNISA-996201971203316 |
| Malden, MA, : Blackwell Pub. Ltd, 2006 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Curbside consultation in IBD : 49 clinical questions / / [edited by] David T. Rubin, Sonia Friedman, Francis Farraye
| Curbside consultation in IBD : 49 clinical questions / / [edited by] David T. Rubin, Sonia Friedman, Francis Farraye |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Thorofare, New Jersey : , : SLACK Incorporated, , 2015 |
| Descrizione fisica | 1 online resource (265 p.) |
| Disciplina | 616.344 |
| Collana | Curbside Consultation Gastroenterology Series |
| Soggetto topico | Inflammatory bowel diseases |
| ISBN | 1-63091-078-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""Cover""; ""Contents""; ""SECTION I""; ""1""; ""2""; ""3""; ""4""; ""5""; ""6""; ""7""; ""8""; ""9""; ""10""; ""11""; ""SECTION II""; ""12""; ""13""; ""14""; ""15""; ""16""; ""17""; ""18""; ""19""; ""20""; ""21""; ""22""; ""23""; ""24""; ""25""; ""26""; ""27""; ""28""; ""29""; ""30""; ""31""; ""32""; ""33""; ""SECTION III""; ""34""; ""35""; ""36""; ""37""; ""SECTION IV""; ""38""; ""39""; ""40""; ""41""; ""42""; ""43""; ""44""; ""45""; ""46""; ""47""; ""48""; ""49"" |
| Record Nr. | UNINA-9910786529803321 |
| Thorofare, New Jersey : , : SLACK Incorporated, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Curbside consultation in IBD : 49 clinical questions / / [edited by] David T. Rubin, Sonia Friedman, Francis Farraye
| Curbside consultation in IBD : 49 clinical questions / / [edited by] David T. Rubin, Sonia Friedman, Francis Farraye |
| Edizione | [2nd ed.] |
| Pubbl/distr/stampa | Thorofare, New Jersey : , : SLACK Incorporated, , 2015 |
| Descrizione fisica | 1 online resource (265 p.) |
| Disciplina | 616.344 |
| Collana | Curbside Consultation Gastroenterology Series |
| Soggetto topico | Inflammatory bowel diseases |
| ISBN | 1-63091-078-3 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Nota di contenuto | ""Cover""; ""Contents""; ""SECTION I""; ""1""; ""2""; ""3""; ""4""; ""5""; ""6""; ""7""; ""8""; ""9""; ""10""; ""11""; ""SECTION II""; ""12""; ""13""; ""14""; ""15""; ""16""; ""17""; ""18""; ""19""; ""20""; ""21""; ""22""; ""23""; ""24""; ""25""; ""26""; ""27""; ""28""; ""29""; ""30""; ""31""; ""32""; ""33""; ""SECTION III""; ""34""; ""35""; ""36""; ""37""; ""SECTION IV""; ""38""; ""39""; ""40""; ""41""; ""42""; ""43""; ""44""; ""45""; ""46""; ""47""; ""48""; ""49"" |
| Record Nr. | UNINA-9910827642703321 |
| Thorofare, New Jersey : , : SLACK Incorporated, , 2015 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Curbside consultation in IBD : 49 clinical questions / / edited by David T. Rubin, Sonia Friedman, Francis A. Farraye
| Curbside consultation in IBD : 49 clinical questions / / edited by David T. Rubin, Sonia Friedman, Francis A. Farraye |
| Pubbl/distr/stampa | Thorofare, New Jersey : , : SLACK, , [2009] |
| Descrizione fisica | 1 online resource (241 p.) |
| Disciplina | 616.344 |
| Altri autori (Persone) |
RubinDavid T. <1968->
FriedmanSonia FarrayeFrancis A |
| Collana |
Curbside consultation in gastroenterology Curbside consultation in IBD
Curbside consultation in gastroenterology |
| Soggetto topico | Inflammatory bowel diseases |
| ISBN | 1-61711-705-6 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNISA-996339100803316 |
| Thorofare, New Jersey : , : SLACK, , [2009] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. di Salerno | ||
| ||
Endoscopy in Small Bowel Diseases / / edited by Mahesh Goenka, Usha Goenka, Gajanan Rodge
| Endoscopy in Small Bowel Diseases / / edited by Mahesh Goenka, Usha Goenka, Gajanan Rodge |
| Pubbl/distr/stampa | London : , : IntechOpen, , [2021] |
| Descrizione fisica | 1 online resource (130 pages) : illustrations |
| Disciplina | 616.344 |
| Soggetto topico | Inflammatory bowel diseases |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910688414703321 |
| London : , : IntechOpen, , [2021] | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
Fast facts : inflammatory bowel disease / / David S. Rampton, DPhil FRCP, Centre for Immunobiology, Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, Queen Mary, University of London, London, UK, Fergus Shanahan MD DSc, Alimentary Pharmabiotic Centre, Department of Medicine, University College Cork, National University of Ireland and Cork University, Hospital, Cork, Ireland
| Fast facts : inflammatory bowel disease / / David S. Rampton, DPhil FRCP, Centre for Immunobiology, Institute of Cell and Molecular Science, Barts and The London School of Medicine and Dentistry, Queen Mary, University of London, London, UK, Fergus Shanahan MD DSc, Alimentary Pharmabiotic Centre, Department of Medicine, University College Cork, National University of Ireland and Cork University, Hospital, Cork, Ireland |
| Autore | Rampton David |
| Edizione | [Fifth edition.] |
| Pubbl/distr/stampa | Abingdon : , : Health Press, , 2016 |
| Descrizione fisica | 1 online resource (153 pages) : color illustrations |
| Collana | Fast facts |
| Soggetto topico | Inflammatory bowel diseases |
| ISBN | 1-910797-17-0 |
| Formato | Materiale a stampa |
| Livello bibliografico | Monografia |
| Lingua di pubblicazione | eng |
| Record Nr. | UNINA-9910158597403321 |
|
Rampton David
|
||
| Abingdon : , : Health Press, , 2016 | ||
| Materiale a stampa | ||
| Lo trovi qui: Univ. Federico II | ||
| ||
